oxide (NO), was a critical regulator of vasodilation, hemostasis, and vascular inflammation, immediately presented a number of stark paradoxes. Most notably, the formation of NO in endothelium and tissue could increase oxygen delivery to tissue by direct vasodilation and recruitment of oxygen rich blood but paradoxically could compete directly with critical oxygen binding sites on oxygen carrier and storage proteins (ie, hemoglobin and myoglobin) and on heme proteins of the mitochondrial electron transport chain (METC). Consistent with such an activity for NO, it was recognized that NO binds with relatively high affinity to cytochrome c oxidase (complex IV) of the METC. [1] [2] [3] Thus, the paradox: why would a molecule that is apparently essential for vasodilation and oxygen delivery directly bind to and inhibit mitochondrial electron transport? Such an activity, by inhibition of respiration and subsequent ATP generation, could represent an innate poison pill, analogous to cyanide.
Interestingly, the binding of NO to cytochrome c oxidase is unique for 2 major reasons (1) Unlike the binding of NO to deoxyhemoglobin or myoglobin, which has a very low dissociation rate, the binding of NO to cytochrome c oxidase is reversible; NO is released as the enzyme cycles. This means that NO-dependent inhibition of respiration is reversible. 1, 3 (2) Perhaps more importantly, the binding of NO to cytochrome c oxidase is regulated by oxygen, such that NO is a more potent inhibitor of respiration as oxygen tension decreases. 1, 3, 4 The binding of NO to cytochrome c oxidase and the resultant inhibition of respiration would seem detrimental, because ATP depletion would ensue. Indeed, in cases of excessive NO generation, complete inhibition of cytochrome c oxidase has been shown to contribute to pathology. 5 However, at physiological concentrations of NO (such as those generated by basal and stimulated endothelial nitric oxide synthase [eNOS] activity), there is another potentially salutary effect of NO-dependent respiratory inhibition when one considers spatial gas diffusion around a blood vessel. The NO-dependent inhibition of mitochondrial oxygen consumption around an endothelial source of NO results in increased oxygen levels (because of decreased oxygen consumption) in this region. This increases oxygen bioavailability and allows oxygen diffusion deeper into the tissue, effectively extending the oxygen gradient from vessel to tissue and preventing hypoxia deeper in the tissue. 6, 7 To understand this concept, one can consider the perivascular mitochondria as oxygen parasites, consuming oxygen before it can reach deep into tissue. Only 2 ways exist to increase oxygen diffusion to tissue: the first is to increase vasodilation and vascular density, and the second is to decrease oxygen consumption to increase the diffusion of oxygen into the tissue. It is important to note here that because cytochrome c oxidase is present within mitochondria in excess of the amount needed to meet metabolic demand, partial inhibition of the enzyme does not result in the equivalent inhibition of respiration and ATP generation. 8 For example, in isolated heart mitochondria, a 10% inhibition of cytochrome c oxidase activity results in only a 2% inhibition of oxidative phosphorylation. 9 Hence, partial inhibition of perivascular mitochondria can effectively allow oxygen diffusion deeper into the tissue without significantly affecting ATP generation. 7 In this issue of Circulation Research, Victor et al 10 directly test the hypothesis that endogenously produced NO can inhibit oxygen consumption at physiological oxygen tensions and modulate oxygen redistribution to tissues. They examine the effects of basal blood vessel NO production on the consumption of oxygen by mitochondria in an intact blood vessel preparation. They demonstrate that basal eNOS activity regulates oxygen consumption by the NO-dependent inhibition of cytochrome c oxidase. Using respirometry experiments in vessels, they directly measure the rates of oxygen consumption at multiple oxygen concentrations in the physiological range and show that as oxygen tension decreases, the rate of oxygen consumption decreases. Importantly, they show that this effect is NO-dependent as inhibition of NO production using the NO synthase inhibitor N -nitro-L-arginine or the use vascular preparation from eNOS knockout mice increases the rates of oxygen consumption at low oxygen tensions (because of increased mitochondrial respiratory rate in absence of NO). In contrast, treatment with acetylcholine, leading to increased NO via activation of eNOS, decreases the rate of oxygen consumption at low oxygen tensions. In additional experiments, Victor et al further use a fluorescent oxygen probe to show that the NO-dependent inhibition of respiration leads to the redistribution of oxygen in tissues around the vessel. 10 This study confirms, in intact vessels, results previously demonstrated in cell culture and by modeling, and provides direct experimen-tal evidence that NO regulates tissue oxygen diffusion through not only vasodilation, but also through the modulation of mitochondrial oxygen consumption.
Role of NO in Regulating Reactive Oxygen Species Hypoxic Signaling?
Although not evaluated in the present study by Victor et al, 10 an additional potential effect of reversible NO binding to mitochondrial electron transport enzymes would be the generation of reactive oxygen species and the modulation of redox equivalents. Electrons flow through the METC is coupled to the reduction of oxygen to form water and generate proton gradients, which ultimately drive ATP synthesis. Downstream blockade of mitochondrial electron transport at cytochrome c oxidase can result in the accumulation of electrons and reducing equivalents within the mitochondria. In addition to lowering the cellular redox potential, this can result in the reduction of oxygen to form superoxide, rather than water. 11, 12 Although the formation of superoxide is often considered a pathological event, it is now appreciated that this may represent a signaling pathway. 11, 13 Superoxide formed at complexes I to III will be dismutated to hydrogen peroxide by manganese superoxide dismutase located within the mitochondrion. Hydrogen peroxide can diffuse through membranes and is a signaling mediator of a number of physiological responses, including vasodilation. 14 We hypothesize that this pathway may mediate an important hypoxic signaling: as oxygen tension decreases, oxygen is diverted from ATP generation to reactive oxygen species signaling (H 2 O 2 ). Hydrogen peroxide is a known vasodilator, 14 providing a novel pathway to hypoxic vasodilation. Furthermore, the hypoxia inducible factor, hypoxia-inducible factor-1␣, can be activated by oxidation of the prolyl hydroxylase by hydrogen peroxide, providing for mitochondrial derived signals to activate canonical hypoxic transcriptional signaling. 6 Such a pathway is teleologically appealing: the oxygen requiring energy factory of the cell, the mitochondria, when faced with low oxygen substrate, sends direct reactive oxygen species (H 2 O 2 ) signals to its surrounding cellular environment indicating a critical oxygen shortage and possibly directly mediating vasodilation (acute hypoxic rescue) and activation of hypoxia-inducible factor-1␣ (late hypoxic rescue via erythropoiesis, etc).
Do Other Gas Ligands Modulate Oxygen Gradients?
This field of study raises interesting questions about the role of other gas molecule cytochrome c oxidase ligands in this process. It is well known that carbon monoxide, produced by the stress induced heme oxygenase 1 enzyme, can bind to and inhibit cytochrome c oxidase. Although CO has a low binding affinity for soluble guanylate cyclase, suggesting that it does not directly regulate cGMP-dependent signaling, it may be capable of competing with cytochrome c oxidase, in an analogous fashion to NO, to regulate hypoxic oxygen gradients and mitochondrial reactive oxygen species formation. 15 Careful study of the role of HO-1 and CO on hypoxic cellular respiration may help elucidate a role for CO in this biology.
Sources of NO During Hypoxia: NOS or Nitrite?
Whereas Victor et al clearly show that eNOS regulates the NO-dependent regulation of respiration during hypoxia, 10 our research group has explored the effect of nitrite-derived NO in this process. 16 Nitrite is the major tissue and blood store of NO equivalents and is readily reduced to NO via electron and proton transfer reactions by the heme globins hemoglobin and myoglobin and by other enzymes, such as xanthine oxidoreductase, aldehyde dehydrogenase, cytochrome c oxidase, cytochrome c, and possibly the P450 enzyme complex. 17, 18 All of these pathways increase the rate of nitrite reduction to NO as oxygen tension decreases, providing mechanisms for the graded production of NO during progressive hypoxia. 17, 18 We and others have shown that nitrite directly inhibits mitochondrial respiration at low oxygen, 16 analogous to the effects of eNOS-dependent NO inhibition of mitochondrial respiration revealed by Victor et al. 10 The relative importance of eNOS versus nitrite-derived NO in the regulation of respiration is the subject of active present research and is likely to be tissue specific. For example, myoglobin appears to potently convert nitrite to NO under hypoxic conditions, suggesting that in myoglobin rich tissue, such as the heart and skeletal muscle, the nitrite pathway may be important. 16 In contrast, in endothelium, the eNOS source of NO is likely dominant, considering the paucity of heme globins and the abundance of eNOS. A critical question to address will be the K m of the NO synthases for oxygen: because oxygen is required substrate for NO synthesis by the NOS enzymes, the formation of NO by NOS may be limited at low oxygen, thus suggesting a requirement for the oxygen independent NO synthesis pathways (ie, nitrite reduction).
Conclusions and Future Directions
The role of NO in the regulation of mitochondrial respiration at low oxygen tensions likely represents a critical paradigm in hypoxic signaling, via the enhancement in oxygen diffusion, the generation of hypoxic reactive oxygen species signals, and under severe hypoxia, the modulation of hypoxic mitochondrial apoptotic signaling. Provocatively, this signaling nexus may regulate hypoxic vasodilation, hypoxia-inducible factor-1␣ activation and mitochondrial-dependent apoptosis. Although Victor et al 10 have clearly demonstrated that NO can inhibit respiration and modulate oxygen gradients in vessels, future studies are needed to confirm the role of NO in reactive oxygen species signaling and hypoxic vasodilation, to establish the tissue specific origin of NO equivalents (NOS versus nitrite), and to determine whether other gas molecules, such as carbon monoxide, participate in this biology.
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